ArriVent BioPharma prices $75M equity offering

ArriVent BioPharma (NASDAQ:AVBP) has priced a securities offering to raise around $75M in gross proceeds.

The offering includes 2,482,692 shares of common stock, issued at a price to the public of $19.50 per share and, in lieu of common stock to certain investors, pre-funded warrants